Acadia Pharmaceuticals Q4 2025 Earnings Call

Loading viewer...

earnings

Format: PDF earnings

Acadia Pharmaceuticals' fourth quarter and full year 2025 earnings presentation delivered February 25, 2026. The call covers commercial updates on flagship products NUPLAZID and DAYBUE, R&D progress, and financial results for the fiscal year.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from ACADIA Pharmaceuticals

View all →

presentation

presentation

Similar earningss from other companies

Browse all →

Clovis Oncology Rucaparib PARP Inhibitor Ovarian Cancer BRCA Clinical Data

earnings

18 Pages

Clovis Oncology

Sprinklr Q2 FY2025 Earnings Presentation September 2024

earnings